A single-center study suggests the surgery is safe and effective even when tumors are large or located in high-risk areas.

Modifying the physical characteristics of microscopic biomaterials to interact seamlessly with the body's tissues could unlock safer and more effective cancer treatments, according to Virginia Tech ...

Patients with non-metastatic GIST treated with neoadjuvant TKIs prior to surgery experienced a benefit which led to less ...

Solid tumors that originate in the deep internal organs, such as the pancreas, liver, and ovary, have poor prognoses due to the difficulties of diagnosing ...

Modifying the physical characteristics of microscopic biomaterials to interact seamlessly with the body's tissues could ...

Advanced prostate cancer cases are rising sharply in California, outpacing national trends, according to a new study from ...

The global immunodiagnostics market size is calculated at USD 24.20 billion in 2025 and is expected to reach around USD 70.9 ...

In Georgia, a 15-centimeter living parasite was found in the human brain. "This is the first confirmed case of a live ...

The digital pathology software developer is raising funding that would help it to increase its headcount and support its Aiosyn Mitosis Breast application.

Breast cancer is one of the most common cancers worldwide, affecting both women and men, though it is far more prevalent in ...

Epitopea, a transatlantic cancer immunotherapeutics company developing accessible off-the-shelf RNA-based immunotherapies, announces the appointment of Dr. Klaus Edvardsen as its new Chief Medical ...

Oncolytics Biotech® Inc. , a leading clinical-stage company specializing in immunotherapy for oncology, today announced that Matt Coffey, Ph.D., President and Chief Executive Officer, will not return ...